The NF-kappa B inhibitor parthenolide modulates the inflammatory responses in experimental atherosclerosis - Lopez-Franco, O; Hernandez-Vargas, P; Ortiz-Munoz, G; Sanjuan, G; Ortega, L; Egido, J; Gomez-Guerrero, C (Atherosclerosis Supplements, 2005)